ASRIX | MGLMX | ASRIX / MGLMX | |
Total Expense Ratio | 0.91 | 0.94 | 97% |
Annual Report Gross Expense Ratio | 0.91 | 0.95 | 96% |
Fund Existence | 18 years | 10 years | - |
Gain YTD | 4.002 | 2.491 | 161% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 366M | 2.29B | 16% |
Annual Yield % from dividends | 3.83 | 2.53 | 151% |
Returns for 1 year | 4.78 | 3.36 | 142% |
Returns for 3 years | 2.28 | -9.31 | -25% |
Returns for 5 years | 16.80 | 11.23 | 150% |
Returns for 10 years | 26.87 | 23.17 | 116% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PSSIX | 23.82 | N/A | N/A |
Principal SmallCap S&P 600 Index Inst | |||
JNGLX | 65.49 | N/A | N/A |
Janus Henderson Global Life Sciences D | |||
TEOOX | 9.19 | N/A | N/A |
Transamerica Emerging Markets Eq R6 | |||
SIEYX | 13.68 | N/A | N/A |
Saratoga International Equity A | |||
VLIIX | 13.28 | -0.07 | -0.52% |
Value Line Capital Appreciation Instl |